The White House has withdrawn Dr. Heidi Overton's nomination to lead the Food and Drug Administration on November 17, 2026, ahead of a scheduled Senate Health committee vote. Overton faced insurmountable opposition from Senate Republicans, including HELP Committee Chairman Bill Cassidy, over her support for President Donald Trump's executive order altering childhood vaccine schedules. Her withdrawal leaves the FDA without a permanent commissioner following Marty Makary's resignation in May 2026, with acting chief Kyle Diamantas continuing to lead the agency.
Nov 16, 2026 · 2 sources
Nov 12, 2026 · 2 sources
Nov 18, 2026 · 2 sources
Nov 17, 2026 · 4 sources
Story comments
Loading comments…